That Marketing Solution, Inc. (OTCQB: TSTS) Announces They Have Successfully Micellized CBD Oil and Are Working to Monetize This Development

SALT LAKE CITY, UT--(Marketwired - Nov 13, 2015) - That Marketing Solution, Inc. (OTCQB: TSTS), a developer and marketer of health related products and owner of the proprietary Aqua V Micellization process, announced that they have successfully micellized CBD oil and are exploring options to monetize this development.

TSTS President, Matt Smith said the following, "We have hundreds of man hours in perfecting the micellization of CBD oil. This development is huge in our opinion for this billion-dollar market and we believe our micellized CBD oil will be shortly validated as the gold standard and the only real smart option for consumers and marketers of CBD products." Mr. Smith also stated, "Our micellized CBD will allow for flavoring options and delivery methods not currently available while increasing bioavailability."

What Is CBD?

CBD is a phytocannabinoid that is found in industrial hemp and marijuana, which are two different varieties of the Cannabis sativa plant. The current market for CBD as a dietary supplement is based on industrial hemp, not marijuana, because marijuana also contains significant amounts of tetrahydrocannabinol (THC), a phytocannabinoid that is psychoactive and capable of making a person high.

In contrast, industrial hemp contains only negligible amounts of THC, so it will not get you high. While CBD is not psychoactive like THC, it can still have a profound influence on the human brain. 

Legal Status of CBD?

As long as CBD-rich oils are imported or farmed in states where cultivation and production is permitted by state law, CBD-rich hemp oils are legal. But they are not legal if their THC content is above 0.3%. This threshold keeps the distinction between hemp and marijuana in place. (See more at: http://www.nutritionaloutlook.com/womens-health/what-studies-say-about-hemp-cbd#sthash.5rFJoj6q.dpuf)

About That Marketing Solution, Inc. (TSTS): That Marketing Solution Develops and Markets Health Related Products. The company owns and operates Technology around Micellization Manufacturing Process. This Proprietary Micellization Process converts oil based nutrients into water soluble products for better absorption by the cells. For more information visit www.ThatMarketingSolution.com.

About TSTS's Aqua V Technology: The Aqua V Technology is an important scientific discovery that exponentially increases the nutritional benefits of bio-nutrients to the body, while lowering the amount of raw ingredients required to manufacture the nutritional formula. Many of the most important bio-nutrients that people supplement in their diets are fat-soluble. Therefore, the body must micellize the supplement by breaking it down -- which leaves only a portion of the bio-nutrient available for uptake. By using this proprietary technology to adapt the nutrient outside of the body, the uptake is almost immediate, and the formulation has almost no bio-waste in the process. This allows formulators to use less active ingredient in their formulas to get the maximum benefit, and it controls the delivery of the exact amount of nutritional value to the body.

Safe Harbor: This presentation contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the presentation, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this presentation.